Interactive Program Guide
Put your cursor over the icon or photo for a capsule summary or to learn more about our speakers |
7.30-8.00
|
Registration
|
8.00-8.30 |
Opening Ceremony |
8.30-9.00
|
Global ARV Forecasting and access to affordable ARV [ Download ]
Dai Ellis
Dai Ellis serves as Director of the Drug Access Team at the Clinton Foundation
HIV/AIDS Initiative, where he leads the Foundation’s work on reducing the prices
and expanding the availability of antiretroviral drugs. |
9.00-9.30
 |
First-Line Antiretroviral Therapy : Weighing New Evidence [ Download ]
Andrew Hill
Dr Andrew Hill is a visiting Senior Research Fellow at Liverpool University in the
UK, specializing in clinical trial design, pharmacology and economics |
9.30-10.00
|
Second line Antiretroviral Therapy
Approaches to the NRTI and PI components of 2nd Line ART regimens in low
and middle income countries [ Download ]
Jens Lundgren
Jens Lundgren heads the Copenhagen HIV Programme (CHIP) University of
Copenhagen, Denmark;. He is the project leader for EuroSIDA |
BREAK |
10.30 -11.00
|
New NRTIs and New PIs are becoming available. How will they fit into
clinical care? [ Download ]
Jonathan Sapiro
Director, AIDS Service, National Hemophilia Center, Tel Hashomer, Israel .
Clinical Assistant Professor Stanford University School of Medicine Stanford,
California
|
11.00-11.30
|
New Classes of Antiretrovirals: The Role of Integrase and Entry Inhibitors
[ Download ]
David Cooper
Scientia Professor of Medicine, the University of New South Wales, Director of the
Australian National Centre in HIV Epidemiology and Clinical Research and a
co-director of HIV-NAT |
11.30-12.00
|
Pros and cons of early ARV therapy [ Download ]
Sean Emery
Associate Professor and Head of the Therapeutic and Vaccine Research Program ;
National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia |
Satellite Lunchtime Symposium by IDS Marketing Ltd. 12.00-13.30 [ Download ] |
